Shandong Weifang Rainbow Chemical Future Growth
Future criteria checks 4/6
Shandong Weifang Rainbow Chemical is forecast to grow earnings and revenue by 41.2% and 20% per annum respectively while EPS is expected to grow by 40% per annum.
Key information
41.2%
Earnings growth rate
40.0%
EPS growth rate
Chemicals earnings growth | 30.6% |
Revenue growth rate | 20.0% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 10 Jun 2024 |
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 16,907 | 1,608 | N/A | 1,680 | 5 |
12/31/2024 | 13,856 | 1,231 | N/A | 1,096 | 3 |
3/31/2024 | 11,945 | 741 | -1,870 | -1,210 | N/A |
12/31/2023 | 11,485 | 771 | -1,989 | -1,350 | N/A |
9/30/2023 | 11,063 | 829 | -1,678 | -991 | N/A |
6/30/2023 | 11,725 | 950 | -411 | 274 | N/A |
3/31/2023 | 13,574 | 1,209 | 438 | 1,156 | N/A |
1/1/2023 | 14,460 | 1,413 | 774 | 1,371 | N/A |
9/30/2022 | 14,954 | 1,656 | 2,048 | 2,605 | N/A |
6/30/2022 | 13,562 | 1,413 | 1,307 | 1,946 | N/A |
3/31/2022 | 11,104 | 1,091 | 365 | 953 | N/A |
1/1/2022 | 9,797 | 800 | 176 | 791 | N/A |
9/30/2021 | 8,175 | 459 | -451 | 221 | N/A |
6/30/2021 | 7,721 | 443 | -460 | -91 | N/A |
3/31/2021 | 7,310 | 399 | -290 | 59 | N/A |
12/31/2020 | 7,290 | 438 | 190 | 512 | N/A |
12/31/2019 | 6,074 | 339 | 518 | 747 | N/A |
12/31/2018 | 5,402 | 310 | 291 | 438 | N/A |
12/31/2017 | 5,047 | 262 | N/A | 319 | N/A |
12/31/2016 | 3,802 | 238 | N/A | 504 | N/A |
9/30/2016 | 3,474 | 193 | N/A | 503 | N/A |
6/30/2016 | 3,211 | 197 | N/A | 380 | N/A |
3/31/2016 | 3,059 | 191 | N/A | 390 | N/A |
12/31/2015 | 2,907 | 179 | N/A | 400 | N/A |
12/31/2014 | 3,077 | 147 | N/A | 253 | N/A |
12/31/2013 | 2,757 | 286 | N/A | 246 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 301035's forecast earnings growth (41.2% per year) is above the savings rate (2.9%).
Earnings vs Market: 301035's earnings (41.2% per year) are forecast to grow faster than the CN market (22.7% per year).
High Growth Earnings: 301035's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 301035's revenue (20% per year) is forecast to grow faster than the CN market (13.9% per year).
High Growth Revenue: 301035's revenue (20% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 301035's Return on Equity is forecast to be high in 3 years time